Position in MEDP
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,445,127
+$85,829 QoQ
Shares Held
5,092
-28.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MEDP Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026PICTON MAHONEY ASSET MANAGEMENT holds $102,222,185 across 14 Diagnostics & Research names. MEDP ranks #6 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
249,991 | $23,091,668 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
44,543 | $21,894,220 | |
| 3 | NTRA |
Natera, Inc.
|
90,161 | $18,031,298 | |
| 4 | RDNT |
RadNet, Inc.
|
309,120 | $17,276,716 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
95,396 | $16,455,810 | |
| 6 | MEDP |
Medpace Holdings, Inc.
This page
|
5,092 | $2,445,127 | |
| 7 | DGX |
Quest Diagnostics Inc
|
8,030 | $1,573,719 | |
| 8 | A |
Agilent Technologies, Inc.
|
9,297 | $1,059,672 |
All Filings in MEDP
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,445,127 | 5,092 | Shares | Sole | 2026-05-13 | |
| 2024-09-30 | $2,359,298 | 7,068 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,954,611 | 7,174 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $2,926,046 | 7,240 | Shares | Sole | 2024-05-09 | |
| 2022-12-31 | $42,482 | 200 | Shares | Sole | 2023-02-13 | |
| No filing history on record for this holder in this stock. | ||||||